Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F22%3A00076520" target="_blank" >RIV/65269705:_____/22:00076520 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/22:00127430 RIV/00216208:11130/22:10445844 RIV/00216208:11140/22:10445844 RIV/00216208:11150/22:10445844 and 5 more
Result on the web
<a href="https://tcr.amegroups.com/article/view/66943/html" target="_blank" >https://tcr.amegroups.com/article/view/66943/html</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.21037/tcr-22-260" target="_blank" >10.21037/tcr-22-260</a>
Alternative languages
Result language
angličtina
Original language name
Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer
Original language description
Background: Programmed death-ligand 1 (PD-L1) expression is a standard predictor in the selection of immunotherapy for locally advanced/advanced non-small cell lung cancer (NSCLC). However, comedication with corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs) may influence the effectiveness of this treatment as documented in several previous studies. Due to certain molecular linkages between PD-L1 and corticosteroids or NSAIDs, we therefore addressed the question of whether there is a relationship between PD-L1 expression in NSCLC and the use of this comedication. Methods: This is a retrospective study using the Czech tumor registry LUng CAncer focuS (LUCAS), from which patient data were drawn. Independence of two categorical parameters was tested by Pearson's chi-square test. Results: In our group of 1,148 patients, we observed no significant relationship between PD-L1 expression and the use of corticosteroids or NSAIDs. Conclusions: According to our data, treatment with corticosteroids or NSAIDs during biopsy does not affect the expression of PD-L1 and it is therefore not necessary to take this treatment into account in this regard.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Translational Cancer Research
ISSN
2218-676X
e-ISSN
2219-6803
Volume of the periodical
11
Issue of the periodical within the volume
9
Country of publishing house
CN - CHINA
Number of pages
7
Pages from-to
3017-3023
UT code for WoS article
000835374900001
EID of the result in the Scopus database
2-s2.0-85139665893